Related Experiment Video
Updated: Apr 20, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Management of Cryptococcus gattii meningoencephalitis
Carlos Franco-Paredes1, Tanea Womack2, Teri Bohlmeyer2
1Phoebe Putney Memorial Hospital, Albany, GA, USA; Hospital Infantil de Mexico, Federico Gomez, Mexico City, Mexico.
Abstract:
Cryptococcosis is a fungal disease caused by Cryptococcus neoformans and Cryptococcus gattii. By inhalation and subsequent pulmonary infection, it may disseminate to the CNS and cause meningitis or meningoencephalitis. Most cases occur in immunosuppressed hosts, including patients with HIV/AIDS, patients receiving immunosuppressing drugs, and solid organ transplant recipients. However, cryptococcosis also occurs in individuals with apparently healthy immune systems. A growing number of cases are caused by C gattii, with infections occurring in both immunosuppressed and immunocompetent individuals. In the majority of documented cases, treatment of C gattii infection of the CNS requires aggressive management of raised intracranial pressure along with standard antifungal therapy. Early cerebrospinal fluid evacuation is often needed through placement of a percutaneous lumbar drain or ventriculostomy. Furthermore, pharmacological immunosuppression with a high dose of dexamethasone is sometimes needed to ameliorate a persistently increased inflammatory response and to reduce intracranial pressure. In this Grand Round, we present the case of an otherwise healthy adolescent female patient, who, despite aggressive management, succumbed to C gattii meningoencephalitis. We also present a review of the existing literature and discuss optimum clinical management of meningoencephalitis caused by C gattii.
Insights
Cryptococcosis, a fungal infection, can cause severe meningoencephalitis, particularly from Cryptococcus gattii. Aggressive management of intracranial pressure is crucial, even in healthy individuals, but outcomes can still be poor.
Area of Science:
- Mycology
- Infectious Diseases
- Neurology
Background:
- Cryptococcosis is a fungal infection caused by Cryptococcus neoformans and Cryptococcus gattii.
- It often affects immunosuppressed individuals but can also occur in immunocompetent hosts.
- Cryptococcus gattii is increasingly implicated in cryptococcosis, affecting both immune-compromised and healthy individuals.
Observation:
- Cryptococcus gattii can cause central nervous system (CNS) disease, including meningoencephalitis.
- Treatment for CNS cryptococcosis, especially C. gattii, necessitates managing intracranial pressure alongside antifungal therapy.
- Aggressive interventions like cerebrospinal fluid diversion and corticosteroids may be required.
Findings:
- A case of fatal C. gattii meningoencephalitis in a healthy adolescent is presented.
- The study reviews literature on C. gattii meningoencephalitis management.
- Optimal clinical strategies for C. gattii meningoencephalitis are discussed.
Implications:
- Highlights the potential severity of C. gattii infections, even in immunocompetent individuals.
- Emphasizes the critical role of intracranial pressure management in C. gattii CNS infections.
- Informs clinical practice regarding the diagnosis and treatment of cryptococcal meningoencephalitis.
Related Concept Videos
Brain Abscess l: Introduction
Cystic Fibrosis: Management
Sinus disease and chronic...
Endocarditis III: Medical Management
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
